Clinical Trials Logo

Clinical Trial Summary

Healthy subjects take single dose of 80mg atorvastatin, then measured their circulating endothelial microparticles and flow-mediated vasodilation in the brachial artery by ultrasound at different time points.


Clinical Trial Description

n/a


Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Prevention


Related Conditions & MeSH terms

  • Endothelium
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors

NCT number NCT02023892
Study type Interventional
Source Sun Yat-sen University
Contact
Status Not yet recruiting
Phase Phase 4
Start date June 2014

See also
  Status Clinical Trial Phase
Completed NCT03018444 - The Effect of HMG-CoA Reductase Inhibition on Postprandial GLP-1 Secretion N/A
Recruiting NCT05537948 - Efficacy and Safety of Pitavastatin and PCSK9 Inhibitors in Liver Transplant Patients Phase 4
Withdrawn NCT00990834 - Muscle Characteristics Associated With Statin Therapy N/A
Completed NCT01241903 - Early Use of Rosuvastatin in Acute Coronary Syndromes: Targeting Platelet-Leukocyte Interactions Phase 1
Not yet recruiting NCT06423365 - A Tool to Help Patients With Muscle Symptoms After Taking a Statin Medication. N/A
Completed NCT00609063 - The Effect of Statin Medications on Muscle Performance (The STOMP Study) N/A
Completed NCT01200056 - Virtual Histology Findings and Effects of Varying Doses of Atorvastatin Treatment Phase 4
Completed NCT03785509 - The Compliance of DAPT and Statins on Clinical Outcomes in Percutaneous Coronary Intervention Patients
Completed NCT05306990 - Statins in Patients With Type 2 Diabetes Mellitus and Previous History of Acute Coronary Syndrome N/A
Recruiting NCT03414840 - Assessment of Change in Atherosclerotic Plaque by Serial CCTA